Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.
May 2, 2017
0
1
A study led by researchers from KK Women's and Children's Hospital (KKH) has found evidence that pregnant women who consume more of their daily food intake after 7:00 PM, and who consume lower quality diets during pregnancy, ...
Dec 19, 2019
0
1
While people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when they encounter difficulties enrolling and remaining in the trial. Trial withdrawal, although every participant's ...
Dec 7, 2022
0
4
(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child ...
Mar 17, 2022
0
7
A better understanding of how the transcription factor Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma) works is critical to find new ways to improve medications to treat type 2 diabetes. Drugs that activate PPARgamma, ...
Jun 23, 2014
0
0
Hospital size matters when it comes to intensive care units (ICUs) adopting even the most routine prevention policies for catheter-associated urinary tract infections (CAUTI), according to a new study from researchers at ...
Oct 23, 2012
0
0
In a new feature in the New England Journal of Medicine, Michael Saag, M.D., professor with the University of Alabama at Birmingham Division of Infectious Diseases and director of the UAB Center for AIDS Research, details ...
Jun 3, 2021
0
0
Urinary incontinence is a prevalent issue, with anywhere from 25 to 50 percent of women reporting an episode in the past year.
May 30, 2017
0
0
France's drug watchdog on Thursday ended a 13-day alert over a diuretic used to control dangerously high blood pressure among the elderly after two persons who took the pills died.
Jun 20, 2013
0
0
(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food and Drug Administration ...
Dec 10, 2012
0
1
